Goodwill Impairment Risk Assessment for Pre-IPO Groups

The Hong Kong Stock Exchange’s (HKEX) 2024 consultation on listing regime enhancements, coupled with the SFC’s heightened scrutiny of financial reporting standards in 2025, has placed goodwill impairment squarely in the crosshairs of pre-IPO due diligence. For groups with a history of acquisitions—particularly those structured through BVI or Cayman holding vehicles—the risk of a material impairment charge surfacing during the HKEX vetting process is no longer a theoretical accounting concern but a direct threat to listing timelines and valuation. Data from the SFC’s 2024-25 annual report indicates a 34% year-on-year increase in enquiries related to impairment testing methodologies and assumptions, reflecting a regulatory pivot toward scrutinising the quality of earnings and asset backing. A single poorly-supported impairment assessment can trigger a sponsor’s requirement for additional work, delay the A1 filing, or force a restatement of historical financials under HKFRS. For CFOs and company secretaries navigating the route from business combination (BC) to IPO, understanding the mechanics of goodwill impairment risk is now a prerequisite for a smooth listing process.

The Regulatory Framework: HKFRS, HKEX, and the SFC’s Convergence

HKFRS 3 and IAS 36: The Accounting Backbone

Goodwill arises under HKFRS 3 Business Combinations when the consideration transferred in an acquisition exceeds the fair value of identifiable net assets acquired. This intangible asset is not amortised under HKFRS; instead, it is subject to annual impairment testing under HKAS 36 Impairment of Assets. The test requires a comparison of each cash-generating unit’s (CGU) recoverable amount—the higher of fair value less costs of disposal (FVLCD) and value in use (VIU)—against its carrying amount, including allocated goodwill. For pre-IPO groups, the key distinction lies in the CGU identification: a group that has rolled up multiple smaller acquisitions into a single reporting segment may face challenges if the HKEX or the sponsor deems the CGU aggregation inappropriate under HKAS 36.87.

The HKEX’s Listing Rules Chapter 4 and Appendix 16 mandate that a listing applicant’s accountants’ report must comply with HKFRS, with no material departures. In practice, the SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (paragraph 17.6) requires sponsors to exercise “reasonable due diligence” on financial information, including the reasonableness of impairment assumptions. A 2023 SFC enforcement action against a sponsor for failing to challenge management’s overly optimistic revenue growth projections in a VIU model—leading to a subsequent impairment of HKD 450 million—demonstrates the real-world consequences of inadequate scrutiny.

The 2024-2025 Policy Shift: Focus on “Headroom” and Assumption Sensitivity

In December 2024, the HKEX published a consultation paper on proposed enhancements to the listing regime, explicitly flagging goodwill impairment as an area where “investor protection concerns have been raised.” The paper noted that between 2020 and 2023, 27% of new listings on the Main Board disclosed goodwill balances exceeding 15% of total assets at the time of listing, with some cases exceeding 40%. The HKEX’s Listing Committee subsequently issued guidance in Q1 2025 requiring sponsors to include in their due diligence work programmes a specific sensitivity analysis for impairment assumptions—particularly discount rates, long-term growth rates, and forecast revenue CAGR—for any CGU where goodwill represents more than 10% of the group’s net assets.

This regulatory push aligns with the SFC’s 2025 thematic review of financial reporting quality, which found that 62% of reviewed pre-IPO groups had at least one CGU where the “headroom” (excess of recoverable amount over carrying amount) was less than 10% of the carrying amount. The SFC’s circular of March 2025 warned that such narrow headroom “raises a rebuttable presumption of impairment risk” and that sponsors should expect direct enquiries from the SFC’s Corporate Finance Division on the assumptions used.

Practical Impairment Risk Assessment: From BC to A1 Filing

Step 1: Structuring the Acquisition and Initial Goodwill Allocation

The genesis of impairment risk often lies in the acquisition structure. A pre-IPO group that has completed multiple bolt-on acquisitions—for example, a PRC-based technology firm acquiring five smaller software companies through a BVI holding vehicle—must allocate goodwill to the appropriate CGUs at the acquisition date under HKFRS 3.B55-B64. A common error is allocating all goodwill to a single, overly broad CGU (e.g., “the entire group”) to simplify future testing. This approach is problematic because HKAS 36.80 requires that goodwill be tested at the level of the CGU that benefits from the synergies of the combination, and that level “shall not be larger than an operating segment” as defined in HKFRS 8.

For a group with multiple distinct product lines or geographic markets, the sponsor will typically insist on separate CGUs. Consider a hypothetical group with three CGUs: CGU A (PRC enterprise software), CGU B (Hong Kong fintech), and CGU C (Southeast Asian logistics). If the acquisition of the logistics entity was priced at an earnings multiple of 18x when the sector median was 12x, the goodwill allocation to CGU C may be disproportionately high relative to its revenue contribution. The CFO must ensure that the purchase price allocation (PPA) under HKFRS 3 is robustly documented, with external valuation support for intangible assets such as customer relationships, technology, and trademarks. The SFC’s 2025 circular specifically noted that “aggressive” PPA valuations—where intangible assets are undervalued to inflate goodwill—are a red flag, as they shift impairment risk from amortisation (for finite-lived intangibles) to impairment testing (for goodwill).

Step 2: Building the Impairment Model – Assumptions That Attract Scrutiny

The impairment model itself is where most pre-IPO groups face challenges. Under HKAS 36.33-36, the VIU approach is the most common for pre-IPO groups, as FVLCD often lacks a liquid market for the CGU. The VIU model requires management to forecast pre-tax cash flows for a period not exceeding five years (unless a longer period can be justified, per HKAS 36.35), and to apply a pre-tax discount rate that reflects the time value of money and the specific risks of the CGU.

The HKEX’s 2025 guidance identified three assumptions that receive the most regulatory pushback:

1. Discount rate (WACC/pre-tax WACC): For a PRC-based CGU, a pre-tax discount rate below 11% in the current interest rate environment (HIBOR at 4.2% as of May 2025, with PRC risk-free rates at 2.8%) is likely to be challenged. The sponsor will expect a benchmark against the CGU’s weighted average cost of capital (WACC) derived from a capital asset pricing model (CAPM) using comparable company betas. A deviation of more than 100 bps from the benchmark requires a written justification.

2. Long-term growth rate (terminal value): A terminal growth rate exceeding the nominal GDP growth rate of the CGU’s primary market is a common trigger. For a CGU operating in Hong Kong, a terminal growth rate above 3.5% (the HKMA’s 2025 estimate of medium-term trend growth) would need support from industry-specific data. The SFC’s 2023 enforcement action cited a case where a terminal growth rate of 5% was used for a mature retail CGU, resulting in a HKD 120 million impairment that the sponsor had failed to flag.

3. Forecast revenue CAGR: If the group’s historical revenue growth over the three years preceding the acquisition was 8% CAGR, but the impairment model assumes 15% CAGR for the next five years, the sponsor must reconcile this with the business plan. The HKEX’s Listing Committee has stated that “management’s forecasts must be consistent with past performance and market expectations, absent a clear, documented catalyst.”

Step 3: Sensitivity Analysis and Headroom Reporting

HKAS 36.134(f) requires disclosure of the key assumptions used in impairment testing and the sensitivity of the recoverable amount to changes in those assumptions. For a pre-IPO group, the sponsor will typically require a “headroom waterfall” in the due diligence report, showing the impact of a 50 bps increase in the discount rate, a 1% decrease in the terminal growth rate, and a 10% reduction in forecast revenue for each CGU.

If any of these sensitivities results in a recoverable amount falling below the carrying amount—i.e., headroom becomes negative—the group has a “reasonably possible” impairment event under HKAS 36.134(f)(ii). The sponsor must then assess whether an impairment charge should be recognised in the pro forma financial statements included in the listing document. The HKEX’s Guidance Letter GL86-16 (updated 2025) explicitly states that “pro forma financial information should reflect adjustments that are directly attributable to the transaction and factually supportable,” which can include a pre-IPO impairment if the sensitivity analysis indicates a high probability of occurrence.

A real-world example: In the HKEX listing application of a PRC education group in 2024, the sponsor identified that a 100 bps increase in the discount rate would wipe out 80% of the headroom for the group’s largest CGU. The SFC requested additional disclosure in the prospectus, including a risk factor titled “Goodwill Impairment Risk” that quantified the potential impairment range (HKD 50 million to HKD 200 million) under different scenarios. The listing was delayed by four months while the group renegotiated the purchase price allocation for a prior acquisition to reduce goodwill.

The Sponsor’s Role and Documentation Requirements

Due Diligence Work Programme: The “Impairment Chapter”

Under the SFC’s Code of Conduct paragraph 17.6(b), the sponsor must ensure that the listing document does not contain any untrue statement. For goodwill impairment, this translates into a specific work programme that includes:

• Reviewing the PPA reports for each material acquisition, including the valuation methodology for intangible assets. The sponsor will engage an independent valuer if the goodwill exceeds HKD 100 million or 20% of the group’s net assets.
• Testing the mathematical accuracy of the impairment model and verifying the source data for cash flow forecasts against board-approved budgets.
• Benchmarking key assumptions against external data: discount rates against Bloomberg’s WACC database, terminal growth rates against IMF or World Bank country forecasts, and revenue CAGR against industry reports from sources such as Frost & Sullivan or Euromonitor.
• Documenting all challenges to management’s assumptions in a “challenge log,” which the SFC may request during its review of the sponsor’s work.

The SFC’s 2025 circular on sponsor due diligence emphasised that “passive acceptance of management’s forecasts without independent verification is not acceptable.” In practice, this means the sponsor must produce a written report—often 30-50 pages for a group with multiple CGUs—that forms part of the due diligence file.

Disclosure in the Listing Document: Prospectus Requirements

The HKEX’s Listing Rules Appendix 16, paragraph 29, requires the accountants’ report to include a statement of whether any impairment of goodwill has been recognised. For pre-IPO groups, the prospectus must also include a risk factor section that addresses goodwill impairment, particularly if the headroom is narrow. The Guidance Letter GL86-16 recommends that the risk factor should:

• Quantify the goodwill balance as a percentage of total assets and net assets.
• Describe the CGUs and the key assumptions used in impairment testing.
• Disclose the sensitivity of the recoverable amount to changes in assumptions, using a table format.
• State the potential impact on profit or loss if an impairment were to occur.

A well-drafted prospectus will also include a note to the pro forma financial information that explains any impairment adjustments made in connection with the listing. For example, if the group has recognised a pre-IPO impairment of HKD 80 million to align goodwill with the recoverable amount under a stressed scenario, the note should explain the trigger event (e.g., downgraded revenue forecast for a specific CGU) and the methodology used.

Cross-Border Considerations: PRC, BVI, and Hong Kong Structures

PRC Operating Entities and VIE Structures

For groups with PRC operating entities, particularly those using variable interest entity (VIE) structures, goodwill impairment risk is amplified by regulatory uncertainty. The PRC’s Ministry of Finance (MOF) requires that impairment testing for PRC-domiciled entities follow PRC GAAP (CAS No. 8) for statutory reporting, which differs from HKFRS in two key respects: (i) CAS No. 8 requires impairment testing at the individual asset level rather than the CGU level in certain circumstances, and (ii) CAS No. 8 prohibits the reversal of impairment losses once recognised, while HKFRS allows reversal for assets other than goodwill.

A pre-IPO group with a PRC operating subsidiary must reconcile these differences in the accountants’ report. The sponsor will typically require a dual-track impairment model: one under PRC GAAP for statutory financial statements and one under HKFRS for the listing document. If the PRC GAAP model triggers an impairment—for example, due to a downturn in the PRC real estate market affecting a subsidiary—the HKFRS model must incorporate that same impairment, as HKFRS 3.B63 requires that goodwill be tested for impairment at least annually, regardless of jurisdiction.

BVI and Cayman Holding Companies: Jurisdictional Nuances

The BVI Business Companies Act (Cap. 218) and the Cayman Islands Companies Act (as revised) do not prescribe specific impairment testing rules; they defer to the accounting standards adopted by the company’s board. However, the jurisdiction of the holding company affects the legal entity structure for the listing. If the listing vehicle is a Cayman-incorporated entity, the impairment model must be prepared at the consolidated group level under HKFRS, but the legal entity financial statements (for Cayman filing purposes) may follow UK GAAP or IFRS, which are substantively similar to HKFRS for impairment purposes.

A practical challenge arises when the group has acquired a BVI-incorporated subsidiary that holds a PRC operating company. The goodwill may be recorded at the BVI level, but the CGU for impairment testing is the PRC operating company’s cash flows. The CFO must ensure that the legal entity structure does not obscure the economic reality: under HKAS 36.80, goodwill must be allocated to the CGU that benefits from the synergies, which is typically the operating entity, not the intermediate holding company.

Actionable Takeaways for Pre-IPO Groups

1. Conduct a pre-engagement impairment health check at least 12 months before the planned A1 filing, identifying all CGUs with headroom below 15% and engaging an independent valuer for PPA and impairment model support where goodwill exceeds 15% of total assets.

2. Document all key assumptions in a formal impairment assumptions memorandum, including the source data for discount rates (Bloomberg WACC as of a specific date), terminal growth rates (IMF country report for the relevant year), and revenue forecasts (board-approved three-year plan), to withstand sponsor and SFC scrutiny.

3. Prepare a sensitivity analysis table for each CGU with more than HKD 50 million in goodwill, showing the impact of a 50 bps discount rate increase, a 1% terminal growth rate decrease, and a 10% revenue reduction, and include this in the due diligence data room.

4. Reconcile any differences between PRC GAAP and HKFRS impairment testing for groups with PRC operating subsidiaries, and ensure that the accountants’ report includes a clear explanation of the adjustments made to align with HKFRS.

5. Negotiate the purchase price allocation with the vendor at the time of acquisition to minimise excessive goodwill allocation, particularly for bolt-on acquisitions where the purchase price exceeds the sector median earnings multiple by more than 20%, as this directly reduces future impairment risk.